Sign In
Buy SAN
$14.10
-0.0100 (-0.0709%)
At Close: Jul 31, 2026
Santander Hedged And Ready For Higher Rates
08:00am, Wednesday, 13'th Jul 2022
Santander is hedged and ready for higher rates compensating for their high proportion of fixed-rate loans. The bank has a nice dividend yield at 3.8%, which including buybacks brings the total capital
Press Release: Pivotal data demonstrate once-weekly efanesoctocog alfa provides superior bleed protection compared to prior factor prophylaxis
01:45pm, Sunday, 10'th Jul 2022 GlobeNewswire Inc.
Pivotal data demonstrate once-weekly efanesoctocog alfa provides superior bleed protection compared to prior factor prophylaxis
Press Release: Fitusiran prophylaxis reduced bleeds by 61% in people with hemophilia A or B, with or without inhibitors, compared to prior factor or bypassing agent prophylaxis
01:45pm, Sunday, 10'th Jul 2022 GlobeNewswire Inc.
Fitusiran prophylaxis reduced bleeds by 61% in people with hemophilia A or B, with or without inhibitors, compared to prior factor or bypassing agent prophylaxis
Des données pivots démontrent que l’efanesoctogog alpha une fois par semaine confère une protection supérieure contre les saignements, comparativement à une prophylaxie antérieure par facteur
Une prophylaxie par fitusiran a réduit de 61 % les saignements chez les personnes atteintes d’hémophilie A ou B, avec ou sans inhibiteurs, comparativement à une prophylaxie antérieure par facteu
NextEnergy Solar Fund agrees 2-year extension to £70mln Santander credit facility
02:36am, Tuesday, 05'th Jul 2022
NextEnergy Solar Fund Ltd (LSE:NESF) (NESF) has extended its £70mln credit facility with Santander UK by two years, allowing it to take advantage of investment opportunities in the renewable energy s
Sanofi Global Health launches nonprofit Impact® brand for 30 medicines in low-income countries
10:00am, Monday, 04'th Jul 2022 GlobeNewswire Inc.
Sanofi Global Health launches nonprofit Impact® brand for 30 medicines in low-income countries
Sanofi Global Health lance la marque Impact® à but non lucratif pour 30 médicaments destinés aux pays à faible revenu
10:00am, Monday, 04'th Jul 2022 GlobeNewswire Inc.
Sanofi Global Health lance la marque Impact® à but non lucratif pour 30 médicaments destinés aux pays à faible revenu
Citigroup's Mexican unit draws bids from Banorte, Santander: Report
07:13am, Wednesday, 29'th Jun 2022
Citigroup Inc.'s C, -1.30% efforts to sell its Citibanamex consumer banking unit in Mexico has drawn bids from Financiero Banorte GBOOY, -1.50% and Banco Santander SA SAN, -1.03% , Reuters reported on
Communiqué de presse: Xenpozyme® (olipudase alpha) approuvé par la Commission européenne – premier et seul traitement du déficit en sphingomyélinase acide
05:30am, Tuesday, 28'th Jun 2022 GlobeNewswire Inc.
Xenpozyme® (olipudase alpha) approuvé par la Commission européenne – premier et seul traitement du déficit en sphingomyélinase acide
Press Release: Nexviadyme® (avalglucosidase alfa) approved by European Commission as a potential new standard of care for the treatment of Pompe Disease
05:30am, Tuesday, 28'th Jun 2022 GlobeNewswire Inc.
Nexviadyme® (avalglucosidase alfa) approved by European Commission as a potential new standard of care for the treatment of Pompe Disease
Communiqué de presse: Nexviadyme® (avalglucosidase alpha), nouveau traitement de référence potentiel de la maladie de Pompe, a été approuvé par la Commission européenne
05:30am, Tuesday, 28'th Jun 2022 GlobeNewswire Inc.
Nexviadyme® (avalglucosidase alpha), nouveau traitement de référence potentiel de la maladie de Pompe, a été approuvé par la Commission européenne
Press Release: Xenpozyme® (olipudase alfa) approved by European Commission as first and only treatment for ASMD
05:30am, Tuesday, 28'th Jun 2022 GlobeNewswire Inc.
Xenpozyme® (olipudase alfa) approved by European Commission as first and only treatment for ASMD
Spain's Santander hires Credit Suisse, Goldman to look at Citibanamex bid - source
03:31am, Tuesday, 28'th Jun 2022
Spain's Santander has hired Credit Suisse and Goldman Sachs to potentially consider a bid for the Citibanamex, Citigroup's retail bank in Mexico, a source familiar with the process said on Tuesday.
Sanofi: Information concerning the total number of voting rights and shares – May 2022
08:57pm, Monday, 27'th Jun 2022 GlobeNewswire Inc.
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement
